Pulse Biosciences, Inc Common Stock (DE) (PLSE)

Price$24.67

Value ScoreF

Momentum ScoreB

Favorite Metrics

Price vs S&P 500 (26W)81.54%

Price vs S&P 500 (4W)15.05%

VGM Score37.67

Market Capitalization$1.73B

All Metrics

Book Value / Share (Quarterly)$0.97

P/TBV (Annual)11.62x

Indicated Dividend (Annual)$0.00

Revenue Growth (3Y)-20.63%

Cash Flow / Share (Quarterly)$-0.81

Price vs S&P 500 (YTD)71.15%

Gross Margin (TTM)-21.04%

Net Profit Margin (TTM)-7376.70%

EPS (TTM)$-1.10

10-Day Avg Trading Volume0.32M

EPS Excl Extra (TTM)$-1.10

EPS (Annual)$-1.08

ROI (Annual)-90.24%

Gross Margin (Annual)-54.00%

Net Profit Margin (5Y Avg)-12111.99%

Cash / Share (Quarterly)$1.00

ROA (Last FY)-76.99%

EBITD / Share (TTM)$-1.15

ROE (5Y Avg)-125.64%

Operating Margin (TTM)-7692.41%

Cash Flow / Share (Annual)$-0.80

P/B Ratio26.10x

P/B Ratio (Quarterly)22.14x

Net Income / Employee (Annual)$-627,400

EV / Revenue (TTM)2212.95x

Net Interest Coverage (TTM)-129.02x

ROA (TTM)-73.61%

EPS Incl Extra (Annual)$-1.08

Current Ratio (Annual)10.53x

Quick Ratio (Quarterly)6.99x

3-Month Avg Trading Volume0.35M

52-Week Price Return40.13%

Revenue / Employee (TTM)$6,500

Tangible BV / Share (Quarterly)$0.97

P/S Ratio (Annual)4943.55x

Asset Turnover (Annual)0.00x

52-Week High$27.98

Operating Margin (5Y Avg)-12131.87%

EPS Excl Extra (Annual)$-1.08

CapEx CAGR (5Y)-5.31%

Tangible BV CAGR (5Y)25.05%

26-Week Price Return97.47%

Quick Ratio (Annual)10.22x

13-Week Price Return29.60%

Total Debt / Equity (Annual)0.00x

Current Ratio (Quarterly)7.26x

Enterprise Value$1.66B

Asset Turnover (TTM)0.01x

Book Value / Share Growth (5Y)-4.23%

Revenue / Employee (Annual)$3,000

Inventory Turnover (Annual)4.10x

Pretax Margin (Annual)-20794.57%

Cash / Share (Annual)$1.19

3-Month Return Std Dev85.86%

Net Income / Employee (TTM)$-642,800

ROE (Last FY)-90.24%

Net Interest Coverage (Annual)-51.91x

EPS Basic Excl Extra (Annual)$-1.08

Receivables Turnover (TTM)23.33x

Total Debt / Equity (Quarterly)0.00x

EPS Incl Extra (TTM)$-1.10

Receivables Turnover (Annual)22.95x

ROI (TTM)-86.67%

P/S Ratio (TTM)2303.92x

Pretax Margin (5Y Avg)-12111.99%

Revenue / Share (Annual)$0.01

Tangible BV / Share (Annual)$1.18

Price vs S&P 500 (52W)11.93%

Year-to-Date Return82.08%

5-Day Price Return-3.44%

EPS Normalized (Annual)$-1.08

ROA (5Y Avg)-76.26%

Net Profit Margin (Annual)-20794.57%

Month-to-Date Return18.09%

Cash Flow / Share (TTM)$-0.90

EBITD / Share (Annual)$-1.14

Operating Margin (Annual)-21982.57%

LT Debt / Equity (Annual)0.00x

ROI (5Y Avg)-125.20%

LT Debt / Equity (Quarterly)0.00x

EPS Basic Excl Extra (TTM)$-1.10

P/TBV (Quarterly)22.28x

P/B Ratio (Annual)11.54x

Inventory Turnover (TTM)7.70x

Pretax Margin (TTM)-7376.70%

Book Value / Share (Annual)$1.19

Price vs S&P 500 (13W)19.85%

Beta1.66x

Revenue / Share (TTM)$0.01

ROE (TTM)-86.67%

52-Week Low$12.56

vGradeF

mGradeB

vgmGradeD

Show chart for

Earnings Surprise History

Q1 26-0.24est. -0.32

Analyst Recommendations

Feb 2026

Mar 2026

Apr 2026

May 2026

4.25

Industry Peers — Surgical & Medical Instruments(138)

Symbol	Value Score	Growth Score	Momentum Score	Price
PLSEPulse Biosciences, Inc Common Stock (DE)	F	—	B	$24.67
SYKStryker Corporation	C	C	D	$299.46
MMM3M Company	C	F	C	$150.93
BSXBoston Scientific Corp.	C	B	F	$47.98
MDLNMedline Inc. Class A common stock	C	D	D	$35.75
BDXBecton, Dickinson and Co.	B	C	C	$145.33
DXCMDexCom, Inc.	C	B	C	$74.87
RMDResMed Inc.	B	B	D	$186.44
WSTWest Pharmaceutical Services, Inc.	D	C	B	$316.30
SOLVSolventum Corporation	C	D	C	$75.84
PENPenumbra, Inc.	F	C	C	$318.95

About

Pulse Biosciences develops Nano-Pulse Stimulation (NPS), a proprietary bioelectric medicine technology that uses precise nanosecond electrical pulses to remove diseased cells while preserving surrounding healthy tissue. The platform addresses multiple medical indications where current treatment options are insufficient or suboptimal. NPS represents a potentially transformative approach for treating conditions across various therapeutic areas.